https://www.selleckchem.com/pr....oducts/valaciclovir-
37, 95% CI 1.92, 21.17; P = 0.003) after adjusting for disease duration and antibodies. We confirm a significant association between high PPI exposure with severity of calcinosis in SSc. Given the clinical impact of calcinosis and reflux in SSc, PPI exposure as a potentially modifiable risk factor for calcinosis requires further evaluation. We confirm a significant association between high PPI exposure with severity of calcinosis in SSc. Given the clinical impact of calcinosis and reflux in SSc, PPI exposure as a potentially mo
Like
Comment
Share
